|
Improving Outcomes for Advanced/Unresectable Hepatocellular Carcinoma: Immune Checkpoint Inhibitor-Based Strategies in First-Line Therapy |
, , , , , |
Oncology |
On-Demand Webcast |
|
Understanding the Latest Developments in the Rapidly Evolving Targeted Therapy and Immunotherapy Treatment Landscape of Advanced Cholangiocarcinoma |
, , , , , |
Oncology |
On-Demand Webcast |
|
Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options |
, , , , , |
Oncology |
On-Demand Webcast |
|
Optimizing Outcomes in Advanced/Metastatic Gastric and Gastroesophageal Junction Cancer: A Focus on Novel and Emerging HER2-Negative Targeted Treatment Strategies |
, , , , , |
Oncology |
On-Demand Webcast |
|
Optimizing Treatment of Non-MSI-H Metastatic Colorectal Cancer with Newer and Emerging Options |
, , , , , |
Oncology |
On-Demand Webcast |
|
Updates and Evidence-Based Strategies in Non-Small Cell Lung Cancer: A Focus on Molecular Testing, Targeted Treatment, and Adverse Event Management |
, , , , , |
Oncology |
Satellite Symposia |
|
Novel Therapeutics and Essential Strategies for Optimized Outcomes in Relapsed/Refractory Multiple Myeloma |
, , , , |
Oncology |
Satellite Symposia |
|
Treatment Advances For Advanced Prostate Cancer: Guideline Updates and Newer Therapies |
, , , , , |
Oncology |
Satellite Symposia |
|
Optimizing the Patient Journey in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Evolving Guidelines, Emerging Options, and Multidisciplinary Management Strategies |
, , , , , |
Oncology |
Satellite Symposia |
|
Opportunities for Improved Outcomes: The Role of Targeted Therapies in Metastatic Urothelial Carcinoma |
, , , , , |
Oncology |
Satellite Symposia |